Summary
The possibility of a circadian rhythm in the toxicity of methotrexate was investigated in rats after a single intravenous bolus. Indices of haematological, renal and hepatic toxicity were studied, as were the pharmacokinetics of the drug. All the parameters showed a circadian variation, with maximum toxicity occurring after dosage at 06.00 h and minimum toxicity after dosage at midnight. Administration at the other two time points, 12.00 h and 18.00 h, gave intermediate results.
Similar content being viewed by others
References
Aherne GW, Piall EM, Marks V (1977) Development and application of a radioimmunoassay for methotrexate. Br J Cancer 36:608
Baker H, Dahl MGC (1969) Methotrexate and the liver. Br J Dermatol 81:465
Brodie BB (1965) Symposium on Drug Interaction. Proc R Soc Med 58:946
Burns ER, Scheving LE (1980) Circadian optimisation of the treatment of L1210 leukaemia with 1-β-d-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone. Chronobiologia 7:41
Cambar J, Lemoigne F, Toussaint C, Dost C (1978) Étude des variations nycthémérales du taux sérique et urinaire de l'urée, de la créatinine et des proteines totales chez le rat. C R Soc Biol 172:894
Cambar J, Lemoigne F, Toussaint C (1979) Étude des variations nycthémérales de la filtration glomérulaire chez le rat. Experientia 35:1607
Condit PT, Chanes RE, Joel W (1969) Renal toxicity of methotrexate. Cancer 2:126
Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA (1948) Temporary remissions in acute leukaemia in children produced by folic acid antagonist, 4-aminopteryl-glutamic acid. N Engl J Med 238:787
Fawcett JK, Scottl JE (1960) Measurement of blood urea nitrogen levels. J Clin Pathol 13:156
Focan C (1979) Sequential chemotherapy and circadian rhythm in human solid tumours. Cancer Chemother Pharmacol 3:197
Goldie JH, Price LA, Harrap KR (1972) Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern. Eur J Cancer 8:409
Halberg F, Haus E, Cardoso SS, Scheving LE, Kuhl JFW, Shiotsuka R, Rosene G, Pauly JE, Runge W, Spalding JF, Lee JK, Good RA (1973) Toward a chronotherapy of neoplasia: tolerance of treatment depends on host rhythms. Experientia 29:909
Hansen HH, Selawry OS, Holland JF, McCall CB (1971) The variability of individual tolerance to methotrexate in cancer patients. Br J Cancer 25:298
Haus E, Halberg F, Scheving LE, Pauly JE, Cardoso S, Kuhl JFW, Southern RB, Shiotsuka RN, Hwang DS (1972) Increased tolerance of leukaemic mice to arabinosyl cytosine with schedule adjusted to circadian rhythm. Science 177:80
Henderson ES, Adamson RH, Denham C, Oliverio VT (1965) The metabolic fate of tritiated methotrexate. 1. Absorption, excretion and distribution in mice, rats, dogs and monkeys. Cancer Res 25:1008
Hrushesky W, Levi F, Kennedy BJ, Theologides A (1981) Results of circadian time qualified chemotherapy in patients with advanced ovarian cancer. ASCO Abstracts C-546:472
Kuhl JFW, Grage TB, Halberg F, Rosene G, Scheving LE, Haus E (1973) Ellen effect: tolerance of adriamycin by Bragg albino mice and Fischer rats depends on circadian timing of injection. Int J Chronobiol 1:335
Levitt M, Mosher MB, DeConti RC, Farber LR, Skeel RT, Marsh JC, Mitchell JLS, Papac RJ, Thomas ED, Bertino JR (1973) Improved therapeutic index of methotrexate with “leucovorin rescue”. Cancer Res 33:1729
Owasoyo JO, Walker CA (1981) Circadian variations of diazepam acute toxicity. Experientia 32:72
Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:56
Rosene G, Lee JK, Kuhl JFW, Halberg F, Grage TB (1973) Adriamycin in advanced L1210 leukaemia. Int J Chronobiol 1:356
Scheving LE, Burns ER, Pauly JE, Halberg F, Haus E (1977) Survival and cure of leukaemic mice after circadian optimisation of treatment with cyclophosphamide and 1-β-d-arabinofuranosyl cytosine. Cancer Res 37:3648
Seelig HP, Wust H (1969) A simple colorimetric method for serum creatinine determination. Aerztl Lab 15:34
Sheving L (1968) Daytime variations in amphetamine disposal. Nature 219:621
Stoller RG, Kaplan HG, Cummings FJ, Calabresi P (1979) A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue. Cancer Res 39:908
Vesell ES (1968) Factors altering the responsiveness of mice to hexobarbital. Pharmacology 1:81
Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton
Zaharko DS, Oliverio VT (1970) Reinvestigation of methotrexate metabolism in rodents. Biochem Pharmacol 19:2923
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
English, J., Wynne Aherne, G. & Marks, V. The effect of timing of a single injection on the toxicity of methotrexate in the rat. Cancer Chemother. Pharmacol. 9, 114–117 (1982). https://doi.org/10.1007/BF00265390
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265390